Mirae Asset Global ETFs Holdings’s Zevra Therapeutics ZVRA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$387K	Buy	27,006 +913	+3%	+$10.1K	﹤0.01%	2132
2026 Q1	$243K	Buy	26,093 +235	+0.9%	+$2.12K	﹤0.01%	2249
2025 Q4	$232K	Buy	25,858 +962	+4%	+$9.1K	﹤0.01%	2280
2025 Q3	$237K	Sell	24,896 -5,364	-18%	-$53.8K	﹤0.01%	2241
2025 Q2	$267K	Sell	30,260 -1,501	-5%	-$12.2K	﹤0.01%	2133
2025 Q1	$238K	Buy	31,761 +1,812	+6%	+$14.4K	﹤0.01%	2238
2024 Q4	$250K	Buy	29,949 +6,877	+30%	+$58.7K	﹤0.01%	2267
2024 Q3	$160K	Buy	23,072 +5,175	+29%	+$35.1K	﹤0.01%	2480
2024 Q2	$87.7K	Buy	+17,897	New	+$84.8K	﹤0.01%	2617

Other funds holding ZVRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ZVRA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Zevra Therapeutics (ZVRA) stake by 3.5% in Q2 2026, buying an estimated $10.1K and bringing the position to 27,006 shares worth $387K. The position accounts for ﹤0.01% of the portfolio, ranked #2132.

Mirae Asset Global ETFs Holdings first reported a position in ZVRA in Q2 2024 and has held it in 9 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

Mirae Asset Global ETFs Holdings held 27,006 shares of Zevra Therapeutics worth $387K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 913 Zevra Therapeutics shares in Q2 2026, an estimated $10.1K.
Zevra Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2132 holding.
Mirae Asset Global ETFs Holdings first reported a position in Zevra Therapeutics in Q2 2024 and has held it in 9 quarters since.
157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.